---
title: "Phreesia"
description: "Phreesia is a publicly traded (NYSE: PHR) healthcare technology company founded in 2005 that provides SaaS-based patient intake, engagement, and activation solutions for healthcare organizations."
date: "2026-01-02"
slug: "phreesia"
published: true
tags: ['competitor-analysis', 'public-company']
excerpt: "Comprehensive competitor analysis"
---

# Phreesia - Comprehensive Research Report

*Research Completed: 2026-01-02*
*Research Depth: Comprehensive*

---

## Executive Summary

Phreesia is a publicly traded (NYSE: PHR) healthcare technology company founded in 2005 that provides SaaS-based patient intake, engagement, and activation solutions for healthcare organizations. The company facilitates approximately 170 million patient visits annually across the United States, representing roughly 1 in 7 healthcare visits nationally. Phreesia has established itself as a market leader in patient intake management, earning Best in KLAS recognition for four consecutive years. The company went public in July 2019 and has grown revenue to $419.8 million in fiscal year 2025 while significantly reducing net losses and approaching profitability.

**Key Facts at a Glance:**
| Attribute | Value |
|-----------|-------|
| **Founded** | 2005 |
| **Headquarters** | Wilmington, DE (All-Remote Company) |
| **Stage** | Public (NYSE: PHR) |
| **IPO Date** | July 18, 2019 |
| **IPO Price** | $18 per share |
| **Total Funding (Pre-IPO)** | ~$167M (IPO) |
| **Employees** | ~2,100 |
| **FY2025 Revenue** | $419.8M |
| **Market Cap** | ~$982M |

---

## 1. Company Overview

### Basic Information

**Legal Name**: Phreesia, Inc. [Accessed 2026-01-02](https://ir.phreesia.com)
**Website**: https://www.phreesia.com
**Founded**: 2005 [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/)
**Headquarters**: Wilmington, Delaware, United States (All-Remote Company) [Accessed 2026-01-02](https://ir.phreesia.com)
**Company Type**: Public Company
**Stock Exchange**: NYSE
**Ticker Symbol**: PHR
**Company Stage**: Growth-stage public company

### Mission & Vision

**Mission**: "To help patients take an active role in their care" and "make care easier every day" [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/)

**Company Purpose**: Phreesia states [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/) their innovative technology "empowers healthcare organizations to better understand their patients and equip them with the knowledge, skills and confidence to succeed."

### Company Description

Phreesia is a Software-as-a-Service (SaaS) company specializing in digital patient intake, engagement, and activation solutions for healthcare organizations. The company claims [Accessed 2026-01-02](https://www.phreesia.com) to be "the trusted leader in patient activation," providing automated tools for intake, access, payments, and more that support patients in taking a more active role in their care.

The company serves over 4,500 healthcare organizations nationwide [Accessed 2026-01-02](https://www.phreesia.com), ranging from single-physician practices to large health systems. Phreesia's platform processes approximately 170 million patient visits annually, which the company states represents approximately 1 in 7 visits across the U.S. [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/)

Phreesia operates as a fully remote company, having transitioned to an all-remote model. The company generates revenue through three primary segments: subscription services, payment processing, and network solutions (life sciences partnerships).

---

## 2. Financial Profile

### Public Company Status

**Stock Exchange**: New York Stock Exchange (NYSE) [2019-07-18](https://ir.phreesia.com/news/news-details/2019/Phreesia-Announces-Pricing-of-Initial-Public-Offering/default.aspx)
**Ticker Symbol**: PHR
**IPO Date**: July 18, 2019 [2019-07-18](https://ir.phreesia.com/news/news-details/2019/Phreesia-Announces-Pricing-of-Initial-Public-Offering/default.aspx)
**IPO Price**: $18 per share [2019-07-19](https://www.fiercehealthcare.com/tech/phreesia-has-strong-public-debut-as-second-digital-health-ipo-2019)
**IPO Valuation**: ~$600 million [2019-08-22](https://news.crunchbase.com/venture/heres-who-has-gone-public-in-2019-so-far/)
**IPO Proceeds**: ~$167 million (9.3 million shares at $18/share) [2025-11-25](https://matrixbcg.com/blogs/owners/phreesia)

### Pre-IPO Funding History

**Total Pre-IPO Funding**: Multiple rounds raised prior to 2019 IPO [Medium confidence]

| Round | Amount | Date | Lead Investor | Other Investors | Source |
|-------|--------|------|---------------|-----------------|--------|
| Series C | $11.6M | 2014 | BlueCross BlueShield Venture Partners | Sandbox Industries, Ascension Health Ventures | [2014](https://www.phreesia.com/news/phreesia-secures-11-6-m-series-c-funding-led-by-bluecross-blueshield-venture-partners-and-sandbox-industries/) |
| Pre-IPO (Final) | $29.4M | Nov 2019 | Multiple | Polaris Partners and 18 other investors | [2025-11-25](https://matrixbcg.com/blogs/owners/phreesia) |

**Key Pre-IPO Investors** [Medium confidence]:
- Polaris Partners
- BlueCross BlueShield Venture Partners
- Sandbox Industries
- Ascension Health Ventures
- HLM Venture Partners
- LLR Partners

### Revenue & Financial Performance

**Annual Revenue History** [High confidence: [Accessed 2026-01-02](https://stockanalysis.com/stocks/phr/revenue/)]:

| Fiscal Year (End Jan 31) | Revenue | YoY Growth |
|--------------------------|---------|------------|
| FY2025 | $419.8M | 17.8% |
| FY2024 | $356.3M | 26.8% |
| FY2023 | $280.9M | 31.7% |
| FY2022 | $213.2M | 43.4% |
| FY2021 | $148.7M | 19.2% |
| FY2020 | $124.8M | 24.9% |
| FY2019 | $99.9M | 25.1% |
| FY2018 | $79.8M | - |

**Recent Quarterly Performance** [High confidence]:
- Q3 FY2026 (ended Oct 31, 2025): $120.3M revenue (+12.7% YoY) [Accessed 2026-01-02](https://stockanalysis.com/stocks/phr/revenue/)
- Q4 FY2025 (ended Jan 31, 2025): $109.7M revenue (+15% YoY) [2025-03-12](https://s24.q4cdn.com/837435241/files/doc_financials/2025/q4/v2/PHR-Ex-99-1-Q4-FY25.pdf)

**Profitability Metrics** [High confidence: [2025-03-12](https://ir.phreesia.com/financials/quarterly-results/)]:
- Net Loss FY2025: $(58.5M), improved from $(136.9M) in FY2024
- Net Loss Q4 FY2025: $(6.4M), improved from $(30.6M) in Q4 FY2024
- Adjusted EBITDA: Turning positive, with continued improvement trajectory

**Revenue per Employee**: ~$222,481 [Accessed 2026-01-02](https://stockanalysis.com/stocks/phr/revenue/)

**Market Capitalization**: ~$982.7M [Accessed 2026-01-02](https://stockanalysis.com/stocks/phr/revenue/)

---

## 3. Product & Technology

### Product Overview

Phreesia provides a comprehensive SaaS platform for patient intake, engagement, and activation. The company claims [Accessed 2026-01-02](https://www.phreesia.com) to deliver "the modern, convenient experience your patients expect" through customized, logic-driven workflows.

### Product Portfolio

| Product/Solution | Description | Target Segment |
|------------------|-------------|----------------|
| **Registration** | Mobile, in-office, and virtual-visit registration with AI-powered intake and customized workflows | All healthcare organizations |
| **Scheduling** | Online appointment scheduling, referrals, and appointment tracking | All segments |
| **Eligibility & Benefits (E&B)** | Unlimited, AI-driven eligibility and benefits verification to reduce claim denials | All segments |
| **Payments/Revenue Cycle** | Insurance verification, e-cashiering, payment plans, and flexible payment options | All segments |
| **Phreesia VoiceAI** | Intelligent 24/7 call automation to answer patient calls | All segments |
| **Procedural Consents** | Digital forms management for complex consent workflows | Health systems, specialty practices |
| **Patient Engagement** | Outreach, education, and patient activation tools | All segments |
| **Analytics/Insights** | Data and reporting analytics across all applications | All segments |
| **Network Solutions** | Life sciences partnerships for patient education and clinical research | Pharma/Life Sciences |
| **PAM (Patient Activation Measure)** | Evidence-based tool measuring patient activation levels | Research, population health |

### Core Capabilities

According to company materials [Accessed 2026-01-02](https://www.phreesia.com):
- Digital registration (mobile, in-office, virtual)
- Online scheduling and appointment management
- Automated appointment reminders
- Insurance eligibility verification
- Payment processing and payment plans
- E-consent and digital forms
- Patient-reported outcomes collection
- Social determinants of health (SDOH) screening
- Care gap closure
- Clinical screening tools
- Referral management
- Population health management

### Technology Approach

**Architecture**: Cloud-based SaaS platform [Accessed 2026-01-02](https://www.phreesia.com)
**Hosting**: Amazon AWS [Accessed 2026-01-02](Apollo enrichment data)
**Key Technical Features**:
- AI-powered eligibility verification
- AI-powered intake automation
- VoiceAI for automated call handling
- FHIR and HL7 integration capabilities
- Real-time analytics
- HIPAA-compliant infrastructure

**Technology Stack** (from Apollo enrichment) [Accessed 2026-01-02]:
- Amazon AWS (cloud infrastructure)
- Marketo (marketing automation)
- Segment.io (analytics)
- Google Analytics
- New Relic (performance monitoring)
- Cloudflare (CDN/security)
- Workday (HR systems)

### Integrations & Platform

**EHR Integrations**: The company claims [Accessed 2026-01-02](https://www.phreesia.com) integration with leading practice management systems and EHRs, including Epic (Dashboard integration with Department Appointments Report).

**Integration Approach**: "Turnkey integrations, tailored workflows and responsive custom interfaces" [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/)

### Intellectual Property

**Patents**: [Not Available: No specific patent count found in public sources]

---

## 4. Leadership & Team

### Executive Team

| Role | Name | Background | Tenure | Source |
|------|------|------------|--------|--------|
| CEO & Co-Founder | Chaim Indig | Prior roles at Spotfire and OLAP@Work; Ernst & Young "Entrepreneur of the Year" finalist | Since 2005 | [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/) |
| President, Provider Solutions & Co-Founder | Evan Roberts | Co-founded Phreesia in 2005 | Since 2005 | [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/) |
| Chief Financial Officer | Balaji Gandhi | Appointed March 2023 | Since 2023 | [2023-03-22](https://www.citybiz.co/article/395636/phreesia-appoints-balaji-gandhi-cfo/) |
| President, Network Solutions | David Linetsky | SVP, Life Sciences | Current | [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/) |
| Chief Technology Officer | Jack Callahan | - | Current | [Accessed 2026-01-02](https://ir.phreesia.com/about-us/executive-management/) |
| General Counsel & Secretary | Allison C. Hoffman | J.D. | Current | [Accessed 2026-01-02](https://finance.yahoo.com/quote/PHR/profile/) |
| SVP, Human Resources | Amy VanDuyn | - | Current | [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/) |
| Chief Privacy Officer | Melissa Mitchell | - | Current | [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/) |
| Chief Information Security Officer | Nick Kemske | - | Current | [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/) |

### Detailed Executive Profiles

**Chaim Indig** - Chief Executive Officer & Co-Founder
- Co-founded Phreesia in January 2005
- Under his leadership, Phreesia has established a broad national footprint and developed strategic partnerships with major healthcare companies
- Prior experience at Spotfire and OLAP@Work
- Ernst & Young "Entrepreneur of the Year" Award finalist
- Featured in Stanford Social Innovation Review as a healthcare innovator
- Total compensation: ~$10.5M (FY2024) [Accessed 2026-01-02](https://simplywall.st/stocks/us/healthcare/nyse-phr/phreesia/management)
- Direct ownership: ~2.29% of company shares (~$23M value)
- Born: 1980 [Accessed 2026-01-02](https://finance.yahoo.com/quote/PHR/profile/)
- Source: [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/)

**Evan Roberts** - President, Provider Solutions & Co-Founder
- Co-founded Phreesia in 2005
- Born: 1980 [Accessed 2026-01-02](https://finance.yahoo.com/quote/PHR/profile/)
- Source: [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/)

**Balaji Gandhi** - Chief Financial Officer
- Joined Phreesia as CFO in March 2023
- Born: 1975 [Accessed 2026-01-02](https://finance.yahoo.com/quote/PHR/profile/)
- Source: [2023-03-22](https://www.citybiz.co/article/395636/phreesia-appoints-balaji-gandhi-cfo/)

### Board of Directors

| Name | Role | Affiliation | Source |
|------|------|-------------|--------|
| Michael Weintraub | Chairman of the Board | Co-Founder & Managing Partner, Ardan Equity; Founding Chair of Phreesia | [Accessed 2026-01-02](https://ir.phreesia.com/about-us/board-of-directors/) |
| Chaim Indig | CEO & Director | Phreesia | [Accessed 2026-01-02](https://ir.phreesia.com/about-us/board-of-directors/) |
| Bill Conroy | Director | Former CEO of Initiate Systems, Inc. | [Accessed 2026-01-02](https://www.phreesia.com/news/hit-thought-leader-bill-conroy-joins-phreesia-board-of-directors/) |
| Lisa Egbuonu-Davis | Director | Board member at Omega Healthcare Investors, Avanos Medical; Johns Hopkins Medicine Board | [2023-07](https://avanos.investorroom.com/board-of-directors) |
| Lainie Goldstein | Director | CFO (current role unknown) | [Accessed 2026-01-02](https://ir.phreesia.com/about-us/board-of-directors/) |
| Ramin Sayar | Director | Former President; joined board Oct 2021 | [Accessed 2026-01-02](https://www.linkedin.com/in/raminsayar) |

**Chairman Profile - Michael Weintraub**:
- Founding Chair of Phreesia
- Co-Founder and Managing Partner of Ardan Equity (healthcare enterprise software private equity)
- Previously Co-Founder and Managing Partner of Optum Ventures
- Co-Founder and CEO of Humedica (acquired by UnitedHealth Group)
- Former President and CEO of Optum Analytics
- Former Senior Managing Director at Leerink Partners
- Former CEO of PharMetrics (acquired by IMS Health/IQVIA)
- Entrepreneur in Residence at Harvard Business School
- Source: [Accessed 2026-01-02](https://accelerator.childrenshospital.org/about/michael-weintraub/)

### Founders

| Name | Role | Background | Status | Source |
|------|------|------------|--------|--------|
| Chaim Indig | Co-Founder | Prior roles at Spotfire, OLAP@Work | Active - CEO | [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/) |
| Evan Roberts | Co-Founder | - | Active - President, Provider Solutions | [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/) |

### Team Size & Growth

**Current Employees**: ~2,100 [High confidence: Apollo enrichment data [Accessed 2026-01-02]]
- LinkedIn estimate: 1,619 employees [Accessed 2026-01-02](https://www.linkedin.com/company/phreesia)
- Stock Analysis estimate: 2,082 employees [Accessed 2026-01-02](https://stockanalysis.com/stocks/phr/revenue/)
- Apollo data: 2,100 employees [Accessed 2026-01-02]

**Company Structure**: All-remote company [Accessed 2026-01-02](https://ir.phreesia.com)

**Headquarters**: Wilmington, DE (legal) with remote workforce

---

## 5. Customers & Market

### Target Market

**Primary Segment**: Healthcare provider organizations [Accessed 2026-01-02](https://www.phreesia.com)
**Customer Types Served**:
- Health Systems
- Multispecialty Groups
- Children's Hospitals
- Community Health Centers (CHCs) and FQHCs
- Single-specialty practices across 20+ medical specialties

**Geographic Focus**: United States [Accessed 2026-01-02](https://www.phreesia.com)

**Specialties Served** [Accessed 2026-01-02](https://www.phreesia.com):
Behavioral Health, Cardiology, Dermatology, Endocrinology, Family Medicine, Gastroenterology, Internal Medicine, Nephrology, Neurology, OB/GYN, Oncology, Ophthalmology, Orthopedics, Otolaryngology (ENT), Pediatrics, Rheumatology, Urology, and more.

### Customer Base

**Total Healthcare Organization Clients**: 4,500+ [Company claim: [Accessed 2026-01-02](https://www.phreesia.com)]

**Patient Visit Volume**: ~170 million patient visits annually (representing ~1 in 7 U.S. healthcare visits) [Company claim: [Accessed 2026-01-02](https://www.phreesia.com/company/about-us/)]

**Average Healthcare Subscription Clients (AHSCs)**: Company reports expecting AHSCs in fiscal 2026 to increase from fiscal 2025 levels of approximately 3,601+ [2024-12-09](https://ir.phreesia.com/news/news-details/2024/Phreesia-Announces-Third-Quarter-Fiscal-2025-Results/default.aspx)

### Named Customers

| Customer | Type | Source | Date Verified |
|----------|------|--------|---------------|
| AdventHealth | Health System | [2020-08-13](https://www.phreesia.com/news/phreesia-partners-with-adventhealth-to-provide-zero-contact-intake-across-its-hospital-and-ambulatory-care-settings/) | 2020 |
| Piedmont Healthcare | Health System | [Accessed 2026-01-02](https://www.phreesia.com) | Website logo |
| Phoebe | Health System | [Accessed 2026-01-02](https://www.phreesia.com) | Website logo |
| New Jersey Urology | Large Specialty Practice (60+ locations) | [2021-03-30](https://www.phreesia.com/news/phreesia-and-new-jersey-urology-partner-to-standardize-intake-and-improve-patient-experience/) | 2021 |
| Lafayette General Health | Regional Health System | [2019-11-07](https://www.phreesia.com/news/phreesia-and-lafayette-general-health-partner-to-deliver-a-better-patient-experience/) | 2019 |
| MercyOne | Health System | [2021-10-05](https://www.phreesia.com/news/mercyone-and-phreesia-partner-to-address-unmet-social-needs-of-patients/) | 2021 |
| Memorial Health System | Health System (Ohio/WV) | [2020-04-20](https://www.phreesia.com/news/memorial-health-system-and-phreesia-partner-to-respond-to-covid-19/) | 2020 |
| Community Care Physician Network | Physician Network | [Accessed 2026-01-02](https://www.phreesia.com/news/phreesia-partners-with-community-care-physician-network-to-deliver-a-safer-more-engaging-patient-experience-and-address-unmet-social-needs/) | Partnership |
| Moffitt Cancer Center | NCI Comprehensive Cancer Center | [2025-09-04](https://www.phreesia.com/news/phreesia-to-acquire-accessone-expanding-its-suite-of-payment-solutions/) | 2025 |
| Concorde Medical Group | Medical Group | [Accessed 2026-01-02](https://www.phreesia.com/solutions/health-systems/) | Website logo |

### Customer Metrics

**Revenue per AHSC**: Company expects total revenue per AHSC to increase in fiscal 2026 from fiscal 2025 [2024-12-09](https://ir.phreesia.com/news/news-details/2024/Phreesia-Announces-Third-Quarter-Fiscal-2025-Results/default.aspx)

---

## 6. Business Model & Go-to-Market

### Revenue Model

**Revenue Streams** [Accessed 2026-01-02](https://ir.phreesia.com):
1. **Subscription Services**: SaaS platform fees from healthcare provider clients
2. **Payment Processing**: Transaction fees from patient payment processing
3. **Network Solutions**: Life sciences partnerships for patient activation, education, and clinical research recruitment

**Pricing Model**: Subscription-based SaaS with transaction fees [Accessed 2026-01-02](https://www.phreesia.com)

### Go-to-Market Strategy

**Sales Model**: Direct enterprise sales + strategic partnerships [Accessed 2026-01-02](https://www.phreesia.com)

**Key Go-to-Market Elements**:
- Direct sales team for health systems and large practices
- EHR/PM system integration partnerships
- Technology partnerships with healthcare IT vendors
- Life sciences partnerships for Network Solutions

### Partnerships & Channels

**Technology Partnerships** [Accessed 2026-01-02](https://www.phreesia.com/news/):
- Unlimited Systems (oncology EHR) - [2023-03-29](https://www.phreesia.com/news/unlimited-systems-partners-with-phreesia/)
- Compulink (specialty EHR) - [2022-06-07](https://www.phreesia.com/news/compulink-and-phreesia-announce-integrated-intake-solution/)
- Epic (EHR integration via Dashboard/DAR)

**Life Sciences/Network Partners**:
- Sesame Workshop (Sesame Street characters for pediatric patient education) - [2025-09-15](https://www.mmm-online.com/news/sesame-street-characters-phreesia-boost-childrens-health/)
- Various pharmaceutical companies for patient education and clinical trial recruitment

---

## 7. Competitive Context

### Company-Stated Positioning

Phreesia positions itself as "the trusted leader in patient activation" [Accessed 2026-01-02](https://www.phreesia.com) and claims to be the #1 patient intake management solution.

### Third-Party Competitive Placement

**KLAS Research**: Ranked #1 in Patient Intake Management for four consecutive years (2019-2022) [Accessed 2026-01-02](https://www.phreesia.com/solutions/all-specialties/)

**Best in KLAS Awards**: Multiple years of recognition [2022-07-13](https://www.thesoftwarereport.com/the-top-100-software-companies-of-2022/)

**G2/Capterra Category**: Patient Engagement Software, Revenue Cycle Management [Accessed 2026-01-02](https://www.g2.com/categories/revenue-cycle-management)

### Competitive Landscape

**Key Competitors** (based on third-party sources) [Accessed 2026-01-02](https://www.lumahealth.io/competitors/):
- **Artera** (formerly WELL Health) - Patient communication platform
- **Luma Health** - Patient success platform
- **Notable Health** - AI-powered patient engagement
- **Solutionreach** - Patient relationship management
- **TeleVox** - Patient engagement solutions

**Differentiation Claims** [Accessed 2026-01-02](https://www.phreesia.com):
- Scale: 170M+ patient visits annually (~1 in 7 U.S. visits)
- 4,500+ healthcare organization clients
- Four consecutive years as Best in KLAS for Patient Intake Management
- Comprehensive platform spanning intake, payments, and clinical support
- Patient Activation Measure (PAM) - proprietary patient activation assessment tool

---

## 8. Recent Activity (Last 24 Months)

### Timeline

| Date | Event | Details | Source |
|------|-------|---------|--------|
| Sep 2025 | Acquisition Announced | Phreesia to acquire AccessOne for $160M cash | [2025-09-04](https://www.phreesia.com/news/phreesia-to-acquire-accessone-expanding-its-suite-of-payment-solutions/) |
| Sep 2025 | Partnership | Sesame Workshop partnership for pediatric patient education | [2025-09-15](https://www.mmm-online.com/news/sesame-street-characters-phreesia-boost-childrens-health/) |
| Sep 2025 | Earnings | Q2 FY26 results announced | [2025-09-04](https://www.businesswire.com/news/home/20250904689827/en/Phreesia-Announces-Second-Quarter-Fiscal-2026-Results) |
| Dec 2025 | Earnings | Q3 FY26 results; Introduced FY27 outlook | [2025-12-08](https://ir.phreesia.com/news/news-details/2025/Phreesia-Announces-Third-Quarter-Fiscal-2026-Results-and-Introduces-Fiscal-2027-Outlook/default.aspx) |
| Mar 2025 | Earnings | Q4 FY25 and full FY25 results announced | [2025-03-12](https://ir.phreesia.com/news/news-details/2025/Phreesia-Announces-Fourth-Quarter-Fiscal-2025-Results/default.aspx) |
| Dec 2024 | Earnings | Q3 FY25 results announced | [2024-12-09](https://ir.phreesia.com/news/news-details/2024/Phreesia-Announces-Third-Quarter-Fiscal-2025-Results/default.aspx) |
| Mar 2024 | Earnings | Q4 FY24 and full FY24 results | [2024-03-14](https://ir.phreesia.com/news/news-details/2024/Phreesia-Announces-Fourth-Quarter-Fiscal-2024-Results/default.aspx) |
| Oct 2025 | Recognition | CEO Chaim Indig named among Top 25 Healthcare Software Executives of 2025 | [2025-10-02](https://thehealthcaretechnologyreport.com/the-top-25-healthcare-software-executives-of-2025/) |

### Acquisition History

Phreesia has completed multiple acquisitions to expand its platform [Accessed 2026-01-02](https://s24.q4cdn.com/837435241/files/doc_financials/2026/q2/Q2-FY26-IR-Presentation_v2.pdf):

| Company | Date | Type | Details | Source |
|---------|------|------|---------|--------|
| **AccessOne** | Sep 2025 (pending) | Payment Solutions | $160M cash; healthcare receivables financing; ~$35M revenue, ~$11M Adj. EBITDA | [2025-09-04](https://www.phreesia.com/news/phreesia-to-acquire-accessone-expanding-its-suite-of-payment-solutions/) |
| **Access eForms** | FY25 | Forms Management | Procedural consent forms platform | [Accessed 2026-01-02](https://www.phreesia.com/products/registration/) |
| **MediFind** | Q2 FY24 | Patient Navigation | Healthcare provider search/navigation | [Accessed 2026-01-02](https://s24.q4cdn.com/837435241/files/doc_financials/2024/q2/PHR-Q2-FY24-IR-Presentation.pdf) |
| **Insignia Health** | Q4 FY22 | Patient Activation | Developer of Patient Activation Measure (PAM) | [Accessed 2026-01-02](https://s24.q4cdn.com/837435241/files/doc_financials/2026/q1/Q1-FY26-IR-Presentation.pdf) |
| **QueueDr** | Q4 FY21 | Scheduling | Appointment scheduling/waitlist management | [Accessed 2026-01-02](https://s24.q4cdn.com/837435241/files/doc_financials/2026/q1/Q1-FY26-IR-Presentation.pdf) |
| **Two apps from Geisinger and Merck** | Q3 FY21 | Apps | Application acquisitions | [Accessed 2026-01-02](https://s24.q4cdn.com/837435241/files/doc_financials/2026/q1/Q1-FY26-IR-Presentation.pdf) |
| **Vital Score** | FY19 | Patient Assessment | - | [Accessed 2026-01-02](https://s24.q4cdn.com/837435241/files/doc_financials/2026/q1/Q1-FY26-IR-Presentation.pdf) |

### AccessOne Acquisition Details (Pending)

- **Announcement Date**: September 4, 2025 [2025-09-04](https://www.phreesia.com/news/phreesia-to-acquire-accessone-expanding-its-suite-of-payment-solutions/)
- **Purchase Price**: $160 million cash
- **Expected Close**: Q3 or early Q4 FY2026
- **Target**: AccessOne Parent Holdings, Inc. (portfolio company of Frontier Growth)
- **Business**: Healthcare receivables financing; manages ~$450M receivables portfolio
- **Scale**: Serves 160+ provider organizations across 2,500 facilities; facilitates 3M+ payments annually
- **Financial Impact**: Expected to contribute ~$35M annualized revenue and ~$11M annualized Adjusted EBITDA
- **Financing**: Cash from balance sheet + new committed bridge loan

---

## 9. Online Presence & Brand

### Social Media

| Platform | Handle | Followers | Activity | Source |
|----------|--------|-----------|----------|--------|
| LinkedIn | [/company/phreesia](https://www.linkedin.com/company/phreesia) | 65,351 | Active | [Accessed 2026-01-02](https://www.linkedin.com/company/phreesia) |
| Twitter/X | [@phreesia](https://twitter.com/phreesia) | 1,547 | 3,476 tweets | [Accessed 2026-01-02](Twitter API) |
| Facebook | [/Phreesia](https://www.facebook.com/Phreesia) | - | Active | [Accessed 2026-01-02](Apollo data) |

**Twitter Profile Description**: "Phreesia empowers patients to take an active role in their health and achieve better outcomes." [Accessed 2026-01-02]

### Digital Footprint

**Website**: phreesia.com - Active content marketing with blog, insights, and resources [Accessed 2026-01-02](https://www.phreesia.com)

**Content Marketing**:
- Blog with industry insights
- PAM Research Library
- Client success stories
- ROI calculators
- Webinars and events

### Reputation Metrics

**KLAS Research**: #1 in Patient Intake Management (4 consecutive years) [Accessed 2026-01-02](https://www.phreesia.com/solutions/all-specialties/)

**Industry Recognition** [Accessed 2026-01-02](https://www.phreesia.com/company/careers/):
- Best Places to Work 2024
- Bloomberg Gender-Equality Index 2023
- Top CTO 2023 (TSR)
- Top 50 Women Leaders 2024
- Top 50 Software Companies
- A/50 Most Innovative Companies

**Glassdoor**: [Not Available: Specific current rating not found]

---

## 10. Risk Factors & Concerns

### Documented Risk Factors

Per company SEC filings and earnings reports [2025-09-04](https://www.phreesia.com/news/phreesia-to-acquire-accessone-expanding-its-suite-of-payment-solutions/):

**Business Risks**:
- Ability to effectively manage growth and meet growth objectives
- Focus on long-term investments may impact short-term profitability
- Competitive environment in healthcare technology
- Ability to maintain security and availability of platform
- Cybersecurity and data breach risks
- Regulatory compliance (HIPAA, healthcare regulations)
- Integration risks from acquisitions

**Financial Risks**:
- History of net losses (though significantly improving)
- Ability to comply with credit agreement covenants (Capital One)
- Dependence on healthcare provider clients
- Concentration in U.S. market

**Market Risks**:
- Changes in healthcare regulations
- Healthcare industry consolidation
- Economic conditions affecting healthcare spending
- Competition from EHR vendors with embedded patient engagement features

### No Significant Red Flags Found

Research did not reveal any significant documented concerns such as:
- No recent major layoffs announced
- No regulatory investigations or major legal proceedings found
- No executive departures beyond normal transitions
- Financial trajectory improving (losses narrowing significantly)

---

## 11. Research Methodology & Limitations

### Sources Used

**Primary Sources**:
- Phreesia corporate website (phreesia.com) [Accessed 2026-01-02]
- Phreesia Investor Relations (ir.phreesia.com) [Accessed 2026-01-02]
- SEC filings and press releases
- Company earnings announcements

**Secondary Sources**:
- Apollo.io organization enrichment data [Accessed 2026-01-02]
- Stock Analysis (stockanalysis.com) [Accessed 2026-01-02]
- Exa search results
- News articles (FierceHealthcare, Business Wire, etc.)
- LinkedIn company page [Accessed 2026-01-02]
- Twitter/X company profile [Accessed 2026-01-02]

### Research Limitations

**Data Gaps**:
- Detailed pre-IPO funding round information (amounts, dates for Series A, B)
- Specific patent portfolio details
- Detailed competitive market share data
- Current Glassdoor rating
- Detailed employee demographic breakdown

**Confidence Notes**:
- Pre-IPO funding history has limited public detail
- Employee count varies by source (1,619-2,100 range)
- Some customer relationships may be dated (COVID-era partnerships)

**Temporal Limitations**:
- Research current as of January 2, 2026
- Financial data based on most recent earnings (Q3 FY26 ended Oct 31, 2025)
- AccessOne acquisition pending close

### Data Quality Summary

| Category | Completeness | Confidence |
|----------|--------------|------------|
| Basic Info | High | High |
| Funding | Medium | Medium |
| Product | High | High |
| Leadership | High | High |
| Customers | Medium | High |
| Financials | High | High |

---

## 12. Tags

`public-company` `healthcare-technology` `patient-engagement` `saas` `enterprise` `growth-stage` `ai-powered` `us-only`

**Tag Categories**:
- **Customer Segment**: `enterprise` `mid-market` `health-systems`
- **Product Approach**: `platform` `horizontal`
- **Stage**: `growth-stage` `public`
- **Business Model**: `saas` `usage-based` `enterprise-sales`
- **Technology**: `ai-powered` `cloud-native` `api-first`
- **Geographic**: `us-only`
- **Industry**: `healthcare-technology` `patient-engagement` `revenue-cycle-management` `digital-health`

---

*Research completed by Company Deep Researcher Agent*
*Date: 2026-01-02*
